Asset 1

Healthtech & Digital health

Our tech and life sciences teams provide seamless expert advice for global companies and investors in the fast-growing digital health industry. Our clients are renowned investors, from prominent early-stage funds to the largest global venture capital firms, and ambitious global digital health companies who, with our support, are revolutionizing the industry.

Through our established investor network we create transformative funding solutions for clients at all business stages, creating substantial financial foundations for growth and on-going development.

With experts in the UK, Europe, the Middle East, and Asia, together with our key partner collaborations in the US, our specialist approach in the provision of finance and capital raising, regulatory and data privacy, and IP, coupled with cross border expertise, provides the foundations for significant and sustainable global expansion for our clients. Our comprehensive awareness of the regulatory challenges facing emerging digital health companies both internally, and among ecosystem partners, is invaluable.

Supported by our data privacy and security teams, we successfully resolve personal data issues particular to digital and app-based devices and the broader regulatory challenges faced by our clients within a rapidly changing industry.

Similarly, our highly regarded IP team helps digital health companies achieve important milestones by securing, developing, and protecting valuable IP assets. This includes restructuring and executing sophisticated agreements and collaborations, partnerships and licensing agreements, and acquiring and divesting valuable businesses through strategic M&A.

Données et cybersécurité

GDPR Compliance for Digital Health Apps

21 septembre 2023
In-depth analysis

par Dr. Tim Jonathan Schwarz

Cliquer ici pour en savoir plus
Careers

Announcing 14 new partners in the UK and Germany

2 mai 2023

par Shane Gleghorn

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

AI software ChatGPT – actually a medical device?

27 mars 2023
Briefing

par Dr. Daniel Tietjen et Ennio Schwind, LL.M. Eur.

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Karlsruhe Higher Regional Court considers the granting of valuable bonus points for the pre-ordering of prescription medicines using smartphone app

7 février 2023
Quick read

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus

Événements connexes